Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Change in Cash: 2010-2025

Historic Change in Cash for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to $236,000.

  • ProPhase Labs' Change in Cash rose 118.45% to $236,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$96,000, marking a year-over-year increase of 52.24%. This contributed to the annual value of -$931,000 for FY2024, which is 87.59% up from last year.
  • Latest data reveals that ProPhase Labs reported Change in Cash of $236,000 as of Q3 2025, which was up 191.36% from $81,000 recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Change in Cash ranged from a high of $25.9 million in Q1 2021 and a low of -$15.1 million during Q2 2021.
  • Over the past 3 years, ProPhase Labs' median Change in Cash value was $81,000 (recorded in 2025), while the average stood at -$791,273.
  • As far as peak fluctuations go, ProPhase Labs' Change in Cash soared by 9,752.09% in 2021, and later crashed by 10,852.00% in 2022.
  • Over the past 5 years, ProPhase Labs' Change in Cash (Quarterly) stood at -$125,000 in 2021, then plummeted by 10,852.00% to -$13.7 million in 2022, then surged by 106.63% to $907,000 in 2023, then tumbled by 80.49% to $177,000 in 2024, then soared by 118.45% to $236,000 in 2025.
  • Its Change in Cash was $236,000 in Q3 2025, compared to $81,000 in Q2 2025 and -$590,000 in Q1 2025.